Table 1. Baseline characteristics of the included studies.
Author | Country | Research type | Cases (n) | Age (years) | Sex (male/female) | Panel |
---|---|---|---|---|---|---|
Li et al., 2006 (5) | China | Cohort | 30 | N/A | 15/15 | 2B3D |
Jin et al., 2007 (6) | China | Cohort | 110 | 64.0 (46.0–94.0) | 68/42 | 2B3D |
Yang et al., 2007 (7) | China | Cohort | 105 | 60.5 (13.0–94.0) | 66/39 | 2B3D |
Jin et al., 2010 (8) | China | Cohort | 150 | 53.2 (23.0–85.0) | 73/77 | 2B3D |
Meng et al., 2010 (9) | China | Cohort | 128 | 54.6 (24.0–85.0) | 62/66 | 2B3D |
Peng et al., 2015 (10) | China | Cohort | 75 | N/A | 44/31 | 2B3D |
Zhou et al., 2015 (11) | China | Cohort | 80 | N/A | N/A | 2B3D |
Yan et al., 2016 (12) | China | Cohort | 182 | N/A | N/A | 2B3D |
Zheng et al., 2018 (13) | China | Cohort | 245 | N/A | 139/106 | 2B3D |
Bai et al., 2019 (14) | China | Cohort | 271 | 58.0 (18.0–84.0) | 111/160 | 2B3D |
Zheng et al., 2018 (13) | China | Cohort | 245 | N/A | 139/106 | Promega |
Bai et al., 2019 (14) | China | Cohort | 72 | N/A | N/A | Promega |
Jiang et al., 2019 (15) | China | Cohort | 213 | 59.0 (19.0–92.0) | 118/95 | Promega |
Huang et al., 2010 (16) | China | Cohort | 298 | 54.6 | 184/114 | Promega |
Li et al., 2018 (17) | China | Cohort | 240 | N/A | 153/87 | 6 mononucleotide markers |
Wang et al., 2019 (18) | China | Cohort | 40 | N/A | 24/16 | 6 mononucleotide markers |
Song et al., 2020 (19) | China | Cohort | 2,356 | N/A | 1,437/919 | 6 mononucleotide markers |
N/A, not available.